Viral Hepatitis Coinfection
Active Resources: 43
-
Training slides review the difference between HCV genotype 3 and other genotypes, and identify appropriate treatment options for patients with HCV genotype 3 and cirrhosis.
Type: Training MaterialsPublish Date: 9/22/2021 -
Training slides review the impact of SVR and the risk of diabetes in patients treated with DAAs for hepatitis C virus (HCV) compared to untreated patients, and discuss the impact of
Type: Training MaterialsPublish Date: 9/20/2021 -
The purpose of this training is to improve providers’ capacity to screen, medically manage, and provide advanced care for patients with hepatitis C virus (HCV).
Type: Online and Self-Paced LearningPublish Date: 9/9/2021 -
Training slides review the epidemiology of hepatitis C (HCV) among people who use drugs, review treatment as prevention, dispel myths about HCV treatment among people who use drugs and di
Type: Training MaterialsPublish Date: 7/13/2021 -
Training slides cover the basic pharmacokinetic properties of DAAs, review interactions between DAAs and antiretroviral medications and non-HIV medications, and how to modify treatment for HCV or H
Type: Training MaterialsPublish Date: 6/14/2021 -
New England AETC's HIV Resource Library is a compilation of curated resources and education packets on HIV, viral hepatitis, and related public health topics.
Type: Training MaterialsPublish Date: 5/27/2021 -
Training slides provide an epidemiology update, review new AASLD/IDSA practice guidelines, review what to do with treatment interruptions and discuss pregnancy and HCV therapy.
Type: Training MaterialsPublish Date: 5/21/2021 -
Training slides define and review isolated hepatitis B core antibody, isolated anti-HBc, occult HBV infection and the clinical significance, and HBV immunizations, and considerations
Type: Training MaterialsPublish Date: 5/10/2021 -
Recorded on March 17, 2021
Type: Webinar RecordingsPublish Date: 5/4/2021 -
Training slides review various studies on HIV & COVID, tuberculosis, and hepatitis C.
Type: Training MaterialsPublish Date: 4/29/2021 -
Training slides provide information about the importance of treating people with HCV who use drugs to eliminate hepatitis C as a public health threat, dispels common myths about HCV treatment among
Type: Training MaterialsPublish Date: 4/16/2021 -
CT Triple Threat: HIV, Hep C, Opioid Use Disorder Session 1 - The Problem
Recorded on January 12, 2021
After completing this learning session, attendees will be able to:
Type: Webinar RecordingsPublish Date: 2/4/2021Review Date: 5/18/2021 -
Recording of "Combating Discrimination Based on HIV or OUD" on January 13, 2021.
Type: Webinar RecordingsPublish Date: 2/4/2021Review Date: 5/18/2021 -
This series provides best practices and updates for HIV, viral hepatitis, mental health and STI treatment in the correctional setting.
Type: Webinar RecordingsPublish Date: 1/21/2021Review Date: 5/18/2021 -
Training slides reviewing cases of hep B immunity in people with HIV.
Type: Training MaterialsPublish Date: 1/15/2021 -
Hepatitis C Online is a free educational website from the University of Washington National Hepatitis Training Center. This project is funded by the Centers for D
Type: Online and Self-Paced LearningPublish Date: 1/15/2021 -
(Recorded November 9, 2020) This series provides best practices and updates for HIV, viral hepatitis, and STI treatment in the correctional setting.
Type: Webinar RecordingsPublish Date: 12/7/2020Review Date: 5/18/2021 -
(Recorded November 16, 2020) This series provides best practices and updates for HIV, viral hepatitis, and STI treatment in the correctional setting.
Type: Webinar RecordingsPublish Date: 12/7/2020 -
Training slides covering lung cancer screening, practice patterns in hepatitis B vaccination, and heplisav B for people with HIV.
Type: Training MaterialsPublish Date: 11/13/2020 -
About the Program:
Type: Online and Self-Paced LearningPublish Date: 9/19/2020 -
The National HIV Curriculum (NHC) provides free, up-to-date content for clinicians to learn about HIV diagnosis, treatment, and prevention.
Type: Online and Self-Paced LearningPublish Date: 9/14/2020Review Date: 9/8/2021 -
The AETC HIV Comorbidity Community of Practice and Learning has developed three generic (no specific pharmaceuticals identified) template letters for healthcare providers to use for prior auth
Type: Training MaterialsPublish Date: 6/10/2020 -
State-specific resources to assist providers in navigating health coverage requirements that may impact the prescription of hepatitis c treatment.
Type: Clinical Reference ToolsPublish Date: 4/3/2020 -
This toolkit includes webinars, online trainings and resources for both providers and patients such as:
Type: Clinical Reference ToolsPublish Date: 2/28/2020 -
Each year HRSA's HIV/AIDS Bureau sponsors a conference for Ryan White Program clinicians to learn about advances in care and treatment.
Type: Online and Self-Paced LearningPublish Date: 12/4/2019 -
This slide set introduces substance use disorder providers to the issues of HIV and hepatitis C virus (HCV) screening and prevention, recognizing the important role that substance use disorder prov
Type: Training MaterialsPublish Date: 10/1/2019 -
Session facilitated by Lauren Brinkley-Rubinstein, PhD, Assistant Professor of Social Medicine
University of North Carolina at Chapel HillType: Online and Self-Paced LearningPublish Date: 3/15/2019 -
This patient resource is designed to address the reluctance patients sometimes feel regarding hepatitis C treatment initiation based on past experiences with old hepatitis C treatment regimens.
Type: Clinical Reference ToolsPublish Date: 2/26/2019Review Date: 8/15/2021 -
Comprehensive guidelines covering the epidemiology, diagnosis, and treatment of multiple opportunistic infections in children.
Contents:
Type: GuidelinesPublish Date: 2/8/2019 -
Northeast/Caribbean (NECA) AETC offers online continuing education accredited videos and monographs.
Type: Online and Self-Paced LearningPublish Date: 2/5/2019Review Date: 6/11/2021 -
A collection of updated clinical guides regarding drug interactions of HCV direct-acting antivirals (DAAs) with other common primary care medications and HIV antiretrovirals.
Type: Clinical Reference ToolsPublish Date: 2/1/2019 -
Type: Clinical Reference ToolsPublish Date: 11/30/2018 -
HCV treatment is recommended for ALL people with HCV, with rare exceptions1, and substance use is NOT a contraindication to HCV treatment.
Type: Clinical Reference ToolsPublish Date: 11/27/2018Review Date: 7/26/2021 -
The National Alliance of State and Territorial AIDS Directors (NASTAD), in partnership with the Association for Public Health Laboratories, has released Integrating HIV and HCV Testing. Th
Type: Clinical Reference ToolsPublish Date: 10/29/2018 -
The Hep C Free postcard is designed to celebrate and acknowledge patient success when hepatitis C viral suppression is achieved.
Type: Clinical Reference ToolsPublish Date: 5/31/2018Review Date: 11/29/2019 -
Comprehensive guidelines, including:
Type: GuidelinesPublish Date: 5/24/2018Review Date: 9/2/2020 -
In Brief consists of concise summaries of the latest information about HIV, hepatitis, and health disparities organized by topic for easy review.
Type: Training MaterialsPublish Date: 3/22/2018Review Date: 10/7/2019 -
Passport to Cure is an interactive patient engagement brochure. It helps clients track clinic visits and monitor their HCV treatment progress to achieve a sustained viral response.
Type: Clinical Reference ToolsPublish Date: 3/9/2018Review Date: 11/29/2019 -
An estimated 1.2 million persons with HIV live in the United States.
Type: Clinical Reference ToolsPublish Date: 2/7/2018 -
The goal of this project is to provide an evidence-based online curriculum for health care providers and trainers of health care providers to increase their knowledge on human immunodeficiency viru
Type: Online and Self-Paced LearningPublish Date: 7/13/2017Review Date: 12/29/2019 -
This infographic addresses some of the barriers to curing HCV infection among coinfected people with HIV.
Type: Clinical Reference ToolsPublish Date: 3/22/2017 -
Objectives
- Describe the financial impact of HCV treatment
Type: Online and Self-Paced LearningPublish Date: 10/19/2016Review Date: 6/18/2021 -
MMWR 2013; Vol. 62 Early Release
Type: GuidelinesPublish Date: 5/7/2013Review Date: 5/10/2019
Archive Resources: 6
-
Objectives
- Describe HIV associated dementia
Type: Online and Self-Paced LearningPublish Date: 10/18/2017 -
Type: Articles, Reports, and ManualsPublish Date: 1/1/2017Review Date: 4/20/2021
-
Objectives
- Understand how HIV coinfection impacts the natural history of hepatitis C virus (HCV)
Type: Online and Self-Paced LearningPublish Date: 10/26/2016 -
Objectives
- List available HCV direct acting antivirals (DAAs) available for HCV therapy in 2016
Type: Online and Self-Paced LearningPublish Date: 10/12/2016 -
Objectives
- Describe how to evaluate likelihood of disease progression
- Discuss importance of and methods for staging liver disease
Type: Online and Self-Paced LearningPublish Date: 10/5/2016Review Date: 5/18/2021 -
The 69 slides on Occupational Exposure to HIV, HCV, and HBV provide an overview of basic HIV information as well as fulfill the following objectives:
Type: Training MaterialsPublish Date: 1/15/2014
-
Oct 12Utah Sexual Health SummitEvent type: Webinars
-
Oct 20
-
Nov 10Sexual Health in the SyndemicEvent type: Meetings
-
Nov 17
-
Jul 28World Hepatitis DayEvent type: Awareness Days
-
Jul 25
-
May 19Hepatitis Testing DayEvent type: Awareness Days